InsidersTradesSigma
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
7
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-74.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Agenus Inc. Director active across 1 company, notably MiNK Therapeutics, Inc.. Aggregated, 9 reports have been published. Split: 7 buys · 0 sell. Total volume traded: €14.9m. Activity tracked since 19 October 2021. The latest transaction was disclosed on 12 October 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Agenus Inc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
3,173 shares@ US$1.09940.0% of flowCommon StockSEC:0000950170-23-053601:0
Canonical exit: 10 Jan 2024 (T+90)
15,001 shares@ US$1.09190.1% of flowCommon StockSEC:0000950170-23-052408:0
Canonical exit: 2 Jan 2024 (T+90)
29,678 shares@ US$1.51680.1% of flowCommon StockSEC:0000950170-23-045816:0
Canonical exit: 27 Nov 2023 (T+90)
170,244 shares@ US$1.54430.8% of flowCommon StockSEC:0000899243-23-018546:0
Canonical exit: 22 Nov 2023 (T+90)
5,006,397 shares0Common StockSEC:0000950170-23-024556:0
22,065 shares@ US$1.5090.1% of flowCommon StockSEC:0000950170-23-021854:0
Canonical exit: 8 Aug 2023 (T+90)
128,689 shares@ US$1.07890.4% of flowCommon StockSEC:0000950170-23-018401:0
Canonical exit: 1 Aug 2023 (T+90)
4,988,273 shares0Common StockSEC:0000899243-23-012119:0
1,400,000 shares@ US$12.0096.9% of flowCommon StockSEC:0000899243-21-040873:0
Canonical exit: 17 Jan 2022 (T+90)
9 of 9 declarations
About Agenus Inc
AGENUS INC is a declarant with 9 filings in total. In the 9 sampled filings, all transactions are acquisitions in MiNK Therapeutics, Inc. between 2021-10-20 and 2023-10-16, with buy volume of EUR 14902476 and no sell volume.
